...
首页> 外文期刊>Internal medicine. >A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C
【24h】

A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C

机译:接受聚乙二醇干扰素α-2b和利巴韦林联合治疗慢性丙型肝炎的患者的慢性硬膜下血肿

获取原文
获取原文并翻译 | 示例
           

摘要

A 70-year-old man who suffered from chronic hepatitis C was infected with HCV genotype 1 and exhibited a high viral load. He had hypertension and had consumed the equivalent of 50 g of ethanol per day. He was treated with pegylated interferon and ribavirin. After 51 weeks, he developed an unsteady gait while walking and demonstrated Barre's sign on the right foot and a headache. Contrast computed tomography showed a subdural hematoma with a mass effect. The patient was treated with drainage and aspiration surgery via a burr hole. Following the drainage procedure, there were no neurological sequelae. Treatment with pegylated interferon and ribavirin was discontinued. Fortunately, a sustained virological response was achieved.
机译:一名患有慢性丙型肝炎的70岁男子感染了HCV基因型1,并显示出高病毒载量。他患有高血压,每天消耗相当于50克的乙醇。他接受了聚乙二醇化干扰素和利巴韦林的治疗。 51周后,他走路时步态不稳,右脚出现头痛症状并显示了Barre的体征。对比计算机断层扫描显示硬膜下血肿伴有肿块效应。通过毛刺孔对该患者进行了引流和抽吸手术。引流后,没有神经系统后遗症。停止使用聚乙二醇化干扰素和利巴韦林治疗。幸运的是,获得了持续的病毒学应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号